JoVE Logo
Faculty Resource Center

Sign In

从血液高效的iPS细胞生成使用附加体和HDAC抑制剂

DOI :

10.3791/52009-v

October 28th, 2014

October 28th, 2014

12,568 Views

1Clinical Research Division, Fred Hutchinson Cancer Research Center, 2Division of Hematology, The Children's Hospital of Philadelphia, 3Department of Pathology, The Children's Hospital of Philadelphia

在这里,我们描述了一种协议,用于使用基于附加体重编程的策略和组蛋白脱乙酰酶抑制剂的外周血产生的诱导的人多能干细胞。

Tags

92 IPSC iPSC HDAC

-- Views

Related Videos

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved